Sugammadex: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Sugammadex. Educational only — not medical advice.
Labeled uses
Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information .
Source: FDA labeling via NIH DailyMed (set 4f1c7cf8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.